RIVFLOZA
Active substance: nedosiran
INJECTION, SOLUTION · NEDOSIRAN SODIUM 128 mg/.8mL
United StatesActive
Marketing holder: Novo Nordisk
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- NEDOSIRAN SODIUM · 128 mg/.8mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5da1-71d1-886c-22d266dcd7be,01a1208e-4175-7bbd-842a-93c8067a3aba,01a1208f-ae89-75f1-8b67-d36c5d5fb0f6;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0169-5307
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0169-5307 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0169-5307 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0169-5307 · Verified 2026-10-09 · open in source